Royce & Associates’s Tivity Health, Inc. Common Stock TVTY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-131,741
| Closed | -$4.24M | – | 1007 |
|
|
2022
Q1 | $4.24M | Buy |
131,741
+113,064
| +605% | +$3.06M | 0.04% | 588 |
|
|
2021
Q4 | $494K | Sell |
18,677
-1,611
| -8% | -$41K | ﹤0.01% | 890 |
|
|
2021
Q3 | $468K | Buy |
+20,288
| New | +$481K | ﹤0.01% | 907 |
|
|
2020
Q3 | – | Sell |
-4,169
| Closed | -$47K | – | 1198 |
|
|
2020
Q2 | $47K | Sell |
4,169
-4,597
| -52% | -$42K | ﹤0.01% | 1041 |
|
|
2020
Q1 | $55K | Sell |
8,766
-39,282
| -82% | -$634K | ﹤0.01% | 996 |
|
|
2019
Q4 | $978K | Sell |
48,048
-54,894
| -53% | -$1.03M | 0.01% | 810 |
|
|
2019
Q3 | $1.71M | Buy |
102,942
+913
| +0.9% | +$15.8K | 0.02% | 735 |
|
|
2019
Q2 | $1.68M | Buy |
102,029
+12,030
| +13% | +$232K | 0.02% | 759 |
|
|
2019
Q1 | $1.58M | Buy |
89,999
+14,369
| +19% | +$306K | 0.01% | 792 |
|
|
2018
Q4 | $1.88M | Sell |
75,630
-11,517
| -13% | -$383K | 0.02% | 750 |
|
|
2018
Q3 | $2.8M | Buy |
87,147
+328
| +0.4% | +$11.2K | 0.02% | 751 |
|
|
2018
Q2 | $3.06M | Buy |
86,819
+5,770
| +7% | +$213K | 0.02% | 732 |
|
|
2018
Q1 | $3.21M | Sell |
81,049
-39
| -0% | -$1.51K | 0.02% | 712 |
|
|
2017
Q4 | $2.96M | Sell |
81,088
-9,112
| -10% | -$346K | 0.02% | 745 |
|
|
2017
Q3 | $3.68M | Sell |
90,200
-194,904
| -68% | -$7.55M | 0.02% | 673 |
|
|
2017
Q2 | $11.4M | Sell |
285,104
-162,300
| -36% | -$5.43M | 0.08% | 359 |
|
|
2017
Q1 | $13M | Sell |
447,404
-5,500
| -1% | -$145K | 0.09% | 316 |
|
|
2016
Q4 | $10.3M | Sell |
452,904
-158,000
| -26% | -$3.72M | 0.07% | 376 |
|
|
2016
Q3 | $16.2M | Sell |
610,904
-302,300
| -33% | -$6.1M | 0.11% | 269 |
|
|
2016
Q2 | $10.5M | Buy |
913,204
+10,000
| +1% | +$117K | 0.07% | 371 |
|
|
2016
Q1 | $9.11M | Buy |
903,204
+106,500
| +13% | +$1.2M | 0.06% | 419 |
|
|
2015
Q4 | $10.3M | Buy |
796,704
+160,500
| +25% | +$1.95M | 0.06% | 400 |
|
|
2015
Q3 | $7.08M | Buy |
636,204
+210,100
| +49% | +$2.57M | 0.04% | 557 |
|
|
2015
Q2 | $5.11M | Buy |
+426,104
| New | +$7.07M | 0.02% | 727 |
|
|
2014
Q1 | – | Sell |
-377,000
| Closed | -$5.79M | – | 1465 |
|
|
2013
Q4 | $5.79M | Sell |
377,000
-159,000
| -30% | -$2.26M | 0.02% | 825 |
|
|
2013
Q3 | $9.92M | Sell |
536,000
-315,000
| -37% | -$5.7M | 0.03% | 665 |
|
|
2013
Q2 | $14.8M | Buy |
+851,000
| New | +$11.7M | 0.05% | 474 |
|
Other funds holding TVTY
BCMLT
PP
IA
Royce & Associates's TVTY Position: Q2 2022 in Review
Royce & Associates sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 131,741 shares — an estimated $4.24M sold.
Royce & Associates first reported a position in TVTY in Q2 2013 and held it in 27 quarters. The position peaked at $16.2M in Q3 2016. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.
- Royce & Associates reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- Royce & Associates sold 131,741 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $4.24M.
- Royce & Associates first reported a position in Tivity Health, Inc. Common Stock in Q2 2013 and held it in 27 quarters.
- Royce & Associates's Tivity Health, Inc. Common Stock position peaked at $16.2M in Q3 2016.
- 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.
Based on Royce & Associates's 13F filing for Q2 2022, filed 4 Aug 2022.